Literature DB >> 23117300

The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.

Sarai Palanca1, Inmaculada de Juan, Gema Perez-Simó, Eva Barragán, Isabel Chirivella, Eduardo Martínez, Oscar Fuster, Pascual Bolufer.   

Abstract

We recently described a novel g.8097_22733del14637 deletion encompassing exons 3-5 in BRCA1 gene. This rearrangement was detected in 3 of 15 (20 %) breast and/or ovarian cancer families of Eastern Spain. This finding made us suspect that the newly identified deletion could be a founder mutation. To confirm this hypothesis we studied 18 subjects belonging to the three families under study, 11 deletion carriers and 7 non-carriers. We performed a haplotype analysis using two BRCA1 intragenic microsatellite markers and two markers surrounding the BRCA1 locus. The segregation analysis showed one common particular haplotype established by D17S1325, D17S1323, D17S855 and D17S1320 markers detected in the deletion carriers but absent in the non-carriers. Our study sustain that the deletion of exons 3-5 of BRCA1, g.8097_22733del14637, identified in families of southeastern of the Valencian Community is the first founder rearrangement until now reported in Spanish population, confirming the hypothesis that this mutation could have Iberian ancestry.

Entities:  

Mesh:

Year:  2013        PMID: 23117300     DOI: 10.1007/s10689-012-9579-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  27 in total

1.  Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

Authors:  Frans B L Hogervorst; Petra M Nederlof; Johan J P Gille; Cathal J McElgunn; Maartje Grippeling; Roelof Pruntel; Rein Regnerus; Tibor van Welsem; Resie van Spaendonk; Fred H Menko; Irma Kluijt; Charlotte Dommering; Senno Verhoef; Jan P Schouten; Laura J van't Veer; Gerard Pals
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

2.  Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.

Authors:  N Puget; D Stoppa-Lyonnet; O M Sinilnikova; S Pagès; H T Lynch; G M Lenoir; S Mazoyer
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

3.  An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?

Authors:  N Puget; O M Sinilnikova; D Stoppa-Lyonnet; C Audoynaud; S Pagès; H T Lynch; D Goldgar; G M Lenoir; S Mazoyer
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

4.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Authors:  D A Berry; G Parmigiani; J Sanchez; J Schildkraut; E Winer
Journal:  J Natl Cancer Inst       Date:  1997-02-05       Impact factor: 13.506

5.  Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.

Authors:  Sara Gutiérrez-Enríquez; Miguel de la Hoya; Cristina Martínez-Bouzas; Ana Sanchez de Abajo; Teresa Ramón y Cajal; Gemma Llort; Ignacio Blanco; Elena Beristain; Eduardo Díaz-Rubio; Carmen Alonso; María-Isabel Tejada; Trinidad Caldés; Orland Diez
Journal:  Breast Cancer Res Treat       Date:  2006-10-25       Impact factor: 4.872

6.  Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families.

Authors:  Brant C Hendrickson; Thaddeus Judkins; Benjamin D Ward; Kristilyn Eliason; Amie E Deffenbaugh; Lynn Anne Burbidge; Kristin Pyne; Benoît Leclair; Brian E Ward; Thomas Scholl
Journal:  Genes Chromosomes Cancer       Date:  2005-07       Impact factor: 5.006

7.  An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10.

Authors:  E M Rohlfs; N Puget; M L Graham; B L Weber; J E Garber; C Skrzynia; J L Halperin; G M Lenoir; L M Silverman; S Mazoyer
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

8.  The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.

Authors:  Ana Peixoto; Catarina Santos; Patrícia Rocha; Manuela Pinheiro; Sofia Príncipe; Deolinda Pereira; Helena Rodrigues; Fernando Castro; Joaquim Abreu; Leonor Gusmão; António Amorim; Manuel R Teixeira
Journal:  Breast Cancer Res Treat       Date:  2008-03-25       Impact factor: 4.872

9.  Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.

Authors:  M D Miramar; M T Calvo; A Rodriguez; A Antón; F Lorente; E Barrio; A Herrero; J Burriel; A García de Jalón
Journal:  Breast Cancer Res Treat       Date:  2008-01-04       Impact factor: 4.872

10.  MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.

Authors:  Stefanie Engert; Barbara Wappenschmidt; Beate Betz; Karin Kast; Michael Kutsche; Heide Hellebrand; Timm O Goecke; Marion Kiechle; Dieter Niederacher; Rita K Schmutzler; Alfons Meindl
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

View more
  5 in total

1.  Novel bioinformatics quality control metric for next-generation sequencing experiments in the clinical context.

Authors:  Maxim Ivanov; Mikhail Ivanov; Artem Kasianov; Ekaterina Rozhavskaya; Sergey Musienko; Ancha Baranova; Vladislav Mileyko
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

2.  Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements.

Authors:  Laura Fachal; Ana Blanco; Marta Santamariña; Angel Carracedo; Ana Vega
Journal:  PLoS One       Date:  2014-03-31       Impact factor: 3.240

Review 3.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

4.  Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.

Authors:  Veronica Fragoso-Ontiveros; Jose Antonio Velázquez-Aragón; Paulina Maria Nuñez-Martínez; Maria de la Luz Mejía-Aguayo; Silvia Vidal-Millán; Abraham Pedroza-Torres; Yuliana Sánchez-Contreras; Miguel Angel Ramírez-Otero; Rodolfo Muñiz-Mendoza; Julieta Domínguez-Ortíz; Talia Wegman-Ostrosky; Juan Enrique Bargalló-Rocha; Dolores Gallardo-Rincón; Nancy Reynoso-Noveron; Cristian Arriaga-Canon; Abelardo Meneses-García; Luis Alonso Herrera-Montalvo; Rosa Maria Alvarez-Gomez
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

Review 5.  Germline Structural Variations in Cancer Predisposition Genes.

Authors:  Tímea Pócza; Vince Kornél Grolmusz; János Papp; Henriett Butz; Attila Patócs; Anikó Bozsik
Journal:  Front Genet       Date:  2021-04-14       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.